Article
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
Human gene therapy - 1 Feb 2020
Matsumura Yuki, Li Na, Alwaseem Hanan, Pagovich Odelya E, Crystal Ronald G, Greenblatt Matthew B, Stiles Katie M
Abstract excerpt
Aldehyde dehydrogenase type 2 (ALDH2), a key enzyme in ethanol metabolism, processes toxic acetaldehyde to nontoxic acetate. ALDH2 deficiency affects 8% of the world population and 35-45% of East Asians. The ALDH2*2 allele common genetic variant has a glutamic acid-to-lysine substitution at position 487 (E487K) that reduces the oxidizing ability of the enzyme resulting in systemic accumulation of acetaldehyde...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
